Clinical Trials
8 trialsNCT02795988 2025-04-16
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
Imugene Limited
Phase 1/2 Completed
NCT01326871 2024-06-25
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Altor BioScience
Phase 1/2 Completed
NCT02983045 2023-03-13
PIVOT-02
Nektar Therapeutics
Phase 1/2 Completed
NCT01029873 2016-10-27
QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma
Altor BioScience
Phase 1/2 Completed
NCT02575859 2015-10-15
Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 1/2 Completed
NCT00705016 2014-04-30
ADVANTAGE
Merck KGaA, Darmstadt, Germany
Phase 1/2 Completed
NCT00719550 2013-12-05
AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer
Amgen
Phase 1/2 Completed
NCT00082472 2006-04-18
Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
Zivena
Phase 1/2 Unknown